Literature DB >> 27538859

Incidence of Mucinous Metaplasia in the Prostate of FVB/N Mice (Mus musculus).

Leena Latonen1, Paula Kujala2, Tapio Visakorpi3.   

Abstract

Prostate epithelium in mice is considered to be relatively resistant to aged-related changes, as compared with human prostate epithelium, which is prone to spontaneous hyperplasia and cancer, for example. In addition, the incidence of metaplasia in mouse prostate typically is considered to be low. Here we report the incidence of mucinous metaplasia in the prostates of wild-type FVB/N mice. Our histologic study shows that mucinous metaplasia involving goblet cells occurs much more frequently (incidence as high as 50%) in the prostates of aged mice (17-24 mo) than has been reported previously. Mucinous metaplasia in the prostates of laboratory mice may be considerably more frequent than previously appreciated.

Entities:  

Mesh:

Year:  2016        PMID: 27538859      PMCID: PMC4983170     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  13 in total

Review 1.  Three cheers for the goblet cell: maintaining homeostasis in mucosal epithelia.

Authors:  Heather A McCauley; Géraldine Guasch
Journal:  Trends Mol Med       Date:  2015-07-03       Impact factor: 11.951

2.  Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression.

Authors:  Paul Mak; Jiarong Li; Sanjoy Samanta; Cheng Chang; D Joseph Jerry; Roger J Davis; Irwin Leav; Arthur M Mercurio
Journal:  Cell Rep       Date:  2015-03-26       Impact factor: 9.423

3.  Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.

Authors:  David J Mulholland; Linh M Tran; Yunfeng Li; Houjian Cai; Ashkan Morim; Shunyou Wang; Seema Plaisier; Isla P Garraway; Jiaoti Huang; Thomas G Graeber; Hong Wu
Journal:  Cancer Cell       Date:  2011-05-27       Impact factor: 31.743

4.  Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs.

Authors:  Takahiko Suwa; Abraham Nyska; Joseph K Haseman; Joel F Mahler; Robert R Maronpot
Journal:  Toxicol Pathol       Date:  2002 Mar-Apr       Impact factor: 1.902

5.  Deficiency of ERβ and prostate tumorigenesis in FGF8b transgenic mice.

Authors:  Teresa Elo; Lan Yu; Eeva Valve; Sari Mäkelä; Pirkko Härkönen
Journal:  Endocr Relat Cancer       Date:  2014-06-17       Impact factor: 5.678

6.  Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.

Authors:  Michael Ittmann; Jiaoti Huang; Enrico Radaelli; Philip Martin; Sabina Signoretti; Ruth Sullivan; Brian W Simons; Jerrold M Ward; Brian D Robinson; Gerald C Chu; Massimo Loda; George Thomas; Alexander Borowsky; Robert D Cardiff
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

7.  FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units.

Authors:  M Mähler Convenor; M Berard; R Feinstein; A Gallagher; B Illgen-Wilcke; K Pritchett-Corning; M Raspa
Journal:  Lab Anim       Date:  2014-02-04       Impact factor: 2.471

8.  Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice.

Authors:  Alexis Scherl; Jiu-Feng Li; Robert D Cardiff; Nicole Schreiber-Agus
Journal:  Prostate       Date:  2004-06-01       Impact factor: 4.104

Review 9.  Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Authors:  Scott B Shappell; George V Thomas; Richard L Roberts; Ron Herbert; Michael M Ittmann; Mark A Rubin; Peter A Humphrey; John P Sundberg; Nora Rozengurt; Roberto Barrios; Jerrold M Ward; Robert D Cardiff
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

10.  MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.

Authors:  Nicola J Clegg; Suzana S Couto; John Wongvipat; Haley Hieronymus; Brett S Carver; Barry S Taylor; Katharine Ellwood-Yen; William L Gerald; Chris Sander; Charles L Sawyers
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.